Literature DB >> 19228891

Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.

Christopher D Green1, Donald B Jump, L Karl Olson.   

Abstract

Increased basal and loss of glucose-stimulated insulin secretion (GSIS) are hallmarks of beta-cell dysfunction associated with type 2 diabetes. It has been proposed that elevated glucose promotes insulin secretory defects by activating sterol regulatory element binding protein (SREBP)-1c, lipogenic gene expression, and neutral lipid storage. Activation of liver X receptors (LXRs) also activates SREBP-1c and increases lipogenic gene expression and neutral lipid storage but increases basal and GSIS. This study was designed to characterize the changes in de novo fatty acid and triacylglyceride (TAG) synthesis in LXR-activated beta-cells and determine how these changes contribute to elevated basal and GSIS. Treatment of INS-1 beta-cells with LXR agonist T0901317 and elevated glucose led to markedly increased nuclear localization of SREBP-1, lipogenic gene expression, de novo synthesis of monounsaturated fatty acids and TAG, and basal and GSIS. LXR-activated cells had increased fatty acid oxidation and expression of genes involved in mitochondrial beta-oxidation, particularly carnitine palmitoyltransferase-1. Increased basal insulin release from LXR-activated cells coincided with rapid turnover of newly synthesized TAG and required acyl-coenzyme A synthesis and mitochondrial beta-oxidation. GSIS from LXR-activated INS-1 cells required influx of extracellular calcium and lipolysis, suggesting production of lipid-signaling molecules from TAG. Inhibition of diacylglyceride (DAG)-binding proteins, but not classic isoforms of protein kinase C, attenuated GSIS from LXR-activated INS-1 cells. In conclusion, LXR activation in beta-cells exposed to elevated glucose concentrations increases de novo TAG synthesis; subsequent lipolysis produces free fatty acids and DAG, which are oxidized to increase basal insulin release and activate DAG-binding proteins to enhance GSIS, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228891      PMCID: PMC2689804          DOI: 10.1210/en.2008-1039

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  65 in total

Review 1.  Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes.

Authors:  Marc Prentki; Erik Joly; Wissal El-Assaad; Raphaël Roduit
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

2.  Selective proteolytic processing of rat hepatic sterol regulatory element binding protein-1 (SREBP-1) and SREBP-2 during postnatal development.

Authors:  Daniela Botolin; Donald B Jump
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

3.  LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function.

Authors:  Isabelle Gerin; Vernon W Dolinsky; Jonathan G Shackman; Robert T Kennedy; Shian-Huey Chiang; Charles F Burant; Knut R Steffensen; Jan-Ake Gustafsson; Ormond A MacDougald
Journal:  J Biol Chem       Date:  2005-04-13       Impact factor: 5.157

4.  The nuclear receptor LXR is a glucose sensor.

Authors:  Nico Mitro; Puiying A Mak; Leo Vargas; Cristina Godio; Eric Hampton; Valentina Molteni; Andreas Kreusch; Enrique Saez
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

5.  Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes.

Authors:  Y T Zhou; M Shimabukuro; Y Lee; K Koyama; M Higa; T Ferguson; R H Unger
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

6.  Evidence for an anaplerotic/malonyl-CoA pathway in pancreatic beta-cell nutrient signaling.

Authors:  T Brun; E Roche; F Assimacopoulos-Jeannet; B E Corkey; K H Kim; M Prentki
Journal:  Diabetes       Date:  1996-02       Impact factor: 9.461

Review 7.  Glycerolipid metabolism and signaling in health and disease.

Authors:  Marc Prentki; S R Murthy Madiraju
Journal:  Endocr Rev       Date:  2008-07-07       Impact factor: 19.871

8.  Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion.

Authors:  Hindrik Mulder; Shumin Yang; Maria Sörhede Winzell; Cecilia Holm; Bo Ahrén
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

9.  New fluorogenic triacylglycerol analogs as substrates for the determination and chiral discrimination of lipase activities.

Authors:  M Duque; M Graupner; H Stütz; I Wicher; R Zechner; F Paltauf; A Hermetter
Journal:  J Lipid Res       Date:  1996-04       Impact factor: 5.922

10.  Stimulation of acetyl-CoA carboxylase gene expression by glucose requires insulin release and sterol regulatory element binding protein 1c in pancreatic MIN6 beta-cells.

Authors:  Chrysovalantis Andreolas; Gabriela da Silva Xavier; Frederique Diraison; Chao Zhao; Aniko Varadi; Fernando Lopez-Casillas; Pascal Ferré; Fabienne Foufelle; Guy A Rutter
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

View more
  15 in total

1.  Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic β-cells and hepatocytes.

Authors:  Yves Mugabo; Shangang Zhao; Annegrit Seifried; Sari Gezzar; Anfal Al-Mass; Dongwei Zhang; Julien Lamontagne; Camille Attane; Pegah Poursharifi; José Iglesias; Erik Joly; Marie-Line Peyot; Antje Gohla; S R Murthy Madiraju; Marc Prentki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

2.  Inhibition of SCD1 impairs palmitate-derived autophagy at the step of autophagosome-lysosome fusion in pancreatic β-cells.

Authors:  Justyna Janikiewicz; Katarzyna Hanzelka; Anna Dziewulska; Kamil Kozinski; Pawel Dobrzyn; Tytus Bernas; Agnieszka Dobrzyn
Journal:  J Lipid Res       Date:  2015-08-20       Impact factor: 5.922

Review 3.  Nuclear receptors as drug targets for metabolic disease.

Authors:  Ira G Schulman
Journal:  Adv Drug Deliv Rev       Date:  2010-07-22       Impact factor: 15.470

4.  Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species.

Authors:  Christopher D Green; Cansel G Ozguden-Akkoc; Yun Wang; Donald B Jump; L Karl Olson
Journal:  J Lipid Res       Date:  2010-03-12       Impact factor: 5.922

Review 5.  Mechanisms of β-cell functional adaptation to changes in workload.

Authors:  M Wortham; M Sander
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

6.  Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.

Authors:  Z X Meng; Y Yin; J H Lv; M Sha; Y Lin; L Gao; Y X Zhu; Y J Sun; X Han
Journal:  Diabetologia       Date:  2012-03-14       Impact factor: 10.122

7.  Cold Exposure Improves the Anti-diabetic Effect of T0901317 in Streptozotocin-Induced Diabetic Mice.

Authors:  Mingming Gao; Chunbo Zhang; Yongjie Ma; Dexi Liu
Journal:  AAPS J       Date:  2015-03-05       Impact factor: 4.009

8.  Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase.

Authors:  Karine H Hellemans; Jean-Claude Hannaert; Bart Denys; Knut R Steffensen; Cindy Raemdonck; Geert A Martens; Paul P Van Veldhoven; Jan-Ake Gustafsson; Daniel Pipeleers
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

9.  Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling.

Authors:  Takeshi Ogihara; Jen-Chieh Chuang; George L Vestermark; James C Garmey; Robert J Ketchum; Xiaolun Huang; Kenneth L Brayman; Michael O Thorner; Joyce J Repa; Raghavendra G Mirmira; Carmella Evans-Molina
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

10.  Significant association of LXRβ (NR1H2) polymorphisms (rs28514894, rs2303044) with type 2 diabetes mellitus and laboratory characteristics.

Authors:  Mohammad Bagher Sadeghi; Alireza Nakhaee; Ramin Saravani; Saman Sargazi
Journal:  J Diabetes Metab Disord       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.